It has now been~ 30 years since the Alzheimer's disease (AD) research entered what may
be termed the 'molecular era'that began with the identification of the amyloid β protein (Aβ) …

Introduction: Alzheimer's disease (AD) is a daunting public health threat that has prompted
the scientific community's ongoing efforts to decipher the underlying disease mechanism …

Alzheimer's disease (AD) is a progressive neurodegenerative disease for which no cure
exists. There is substantial need for new therapies that offer improved symptomatic benefit …

The amyloid β (Aβ) and tau proteins, which misfold, aggregate, and accumulate in the
Alzheimer's disease (AD) brain, are implicated as central factors in a complex …

Alzheimer's disease is the largest unmet medical need in neurology. Current drugs improve
symptoms, but do not have profound disease-modifying effects. However, in recent years …

Alzheimer's disease is a progressive neurodegenerative disease for which no cure exists.
There is a substantial need for new therapies that offer improved symptomatic benefit and …

ABSTRACT Introduction Alzheimer's Disease (AD) represents a large and growing
challenge to patients, carers and healthcare systems, yet extensive efforts to develop …

Medicinal Chemistry Letters to highlight advances in the pharmacology, medicinal
chemistry, and therapeutic strategies currently under development for Alzheimer's disease …

Alzheimer's disease (AD) has been a global concern for years due to its severe implications
that affects the quality of life of the patients. The available line of therapy for treating …

In recent years, Alzheimer disease (AD) has received great attention as an incurable and
fatal disease that threatens the lives of aging individuals. Debates regarding areas of …